EDP Sciences logo
Authentification abonné
rechercher
Menu
Accueil Tous les numéros Volume 20 / Numéro 86 (2023) Le Nouveau Praticien Vét canine & féline, 20 86 (2023) 16-23 Références
Diabète
Accès gratuit
Numéro
Le Nouveau Praticien Vét canine & féline
Volume 20, Numéro 86, 2023
Diabète
Page(s) 16 - 23
Section Dossier : Diabète sucré chez le chien et le chat – 2e partie
DOI https://doi.org/10.1051/npvcafe/2024016
Publié en ligne 21 juin 2024
  • Niessen SJM, Hazuchova K, Powney SL, Guitian J, Niessen APM, Pion PD, et al. The Big Pet Diabetes Survey: Perceived Frequency and Triggers for Euthanasia. Vet Sci. 2017;4(2):27. [PubMed] [Google Scholar]
  • Glior C. Chapter 33 - Gastrointestinal hormones and the use of non-insulin therapies for diabetes mellitus. In: Feline Endocrinology, Feldman E, Fracassi E and Peterson M. 2019; p. 489–502. (Edra; vol. 1). [Google Scholar]
  • European Society of Veterinary Endocrinolgy. ALIVE Project. Definition: treatment goals of diabetes mellitus 2021 [Internet]. [cité 5 nov 2023]. Disponible sur: https://www.esve.org/alive/search.aspx/ [Google Scholar]
  • Fracassi F. Chapitre 32 : Insulin treatment of diabetes mellitus. In: Feline endocrinology - Feldman E, Fracassi F, Peterson M. Edra. Milano, Italie; 2019; p. 468–81. [Google Scholar]
  • Gostelow R. Chapter 36: Diabetic remission. In: Feline endocrinology - Feldman E, Fracassi F, Peterson M. Edra. Minalo, Italy; 2019; p. 542–55. [Google Scholar]
  • Nack R, DeClue AE. In cats with newly diagnosed diabetes mellitus, use of a near-euglycemic management paradigm improves remission rate over a traditional paradigm. Vet Q. 2014;34(3):132–6. [CrossRef] [PubMed] [Google Scholar]
  • Hafner M, Dietiker-Moretti S, Kaufmann K, Mueller C, Lutz TA, Reusch CE, et al. Intensive intravenous infusion of insulin in diabetic cats. J Vet Intern Med. 2014;28(6):1753–9. [CrossRef] [Google Scholar]
  • Krämer AL, Riederer A, Fracassi F, Boretti FS, Sieber-Ruckstuhl NS, Lutz TA, et al. Glycemic variability in newly diagnosed diabetic cats treated with the glucagon-like peptide-1 analogue exenatide extended release. J Vet Intern Med. 2020;34(6):2287–95. [CrossRef] [PubMed] [Google Scholar]
  • Zini E, Salesov E, Dupont P, Moretto L, Contiero B, Lutz TA, et al. Glucose concentrations after insulin-induced hypoglycemia and glycemic variability in healthy and diabetic cats. J Vet Intern Med. 2018;32(3):978–85. [CrossRef] [PubMed] [Google Scholar]
  • Reusch C., Salesov E. Chapter 35: Monitoring diabetes in cats. In: Feline endocrinology, Feldman E, Fracassi F, Peterson M. Edra. Milano, Italy; 2019; p. 522–41. [Google Scholar]
  • Sallander M, Eliasson J, Hedhammar A. Prevalence and risk factors for the development of diabetes mellitus in Swedish cats. Acta Vet Scand. 2012;54(1):61. [CrossRef] [PubMed] [Google Scholar]
  • Verkest KR, Rand JS, Fleeman LM, Morton JM. Spontaneously obese dogs exhibit greater postprandial glucose, triglyceride, and insulin concentrations than lean dogs. Domest Anim Endocrinol. 2012;42(2):103–12. [CrossRef] [PubMed] [Google Scholar]
  • Behrend E, Holford A, Lathan P, Rucinsky R, Schulman R. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. J Am Anim Hosp Assoc. 2018;54(1):1–21. [CrossRef] [PubMed] [Google Scholar]
  • Gilor C, Rudinsky AJ, Hall MJ. New Approaches to Feline Diabetes Mellitus: Glucagon-like peptide-1 analogs. J Feline Med Surg. 2016;18(9):733–43. [CrossRef] [PubMed] [Google Scholar]
  • Scuderi MA, Ribeiro Petito M, Unniappan S, Waldner C, Mehain S, McMillian CJ, et al. Safety and efficacy assessment of a GLP-1 mimetic: insulin glargine combination for treatment of feline diabetes mellitus. Domest Anim Endocrinol. 2018;65:80–9. [CrossRef] [PubMed] [Google Scholar]
  • Riederer A, Zini E, Salesov E, Fracassi F, Padrutt I, Macha K, et al. Effect of the Glucagon-like Peptide-1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus. J Vet Intern Med. 2016;30(1):92–100. [CrossRef] [Google Scholar]
  • Padrutt I, Lutz TA, Reusch CE, Zini E. Effects of the glucagon-like peptide-1 (GLP-1) analogues exenatide, exenatide extended-release, and of the dipeptidylpeptidase-4 (DPP-4) inhibitor sitagliptin on glucose metabolism in healthy cats. Res Vet Sci. 2015;99:23–9. [CrossRef] [PubMed] [Google Scholar]
  • Hoenig M, Clark M, Schaeffer DJ, Reiche D. Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats. Journal of Veterinary Pharmacology and Therapeutics. 2018;41(2):266–73. [CrossRef] [PubMed] [Google Scholar]
  • Behrend EN, Ward C, Chukwu V, Cook A, Kroh C, Lathan P, Schermerhorn T, Scott-Moncrieff JC, Voth R. Velagliflozin, an SGLT2 inhibitor, as once-daily, oral solution, stand-alone therapy for feline diabetes mellitus - 2023 ACVIM Forum Research Report Program. Journal of Veterinary Internal Medicine. 2023;37(6):2638–60. [CrossRef] [Google Scholar]
  • Niessen S.J.M., Voth R, Kroh C, Hennings L. Once daily oral therapy for feline diabetes mellitus: SGLT-2-inhibitor velagliflozin as stand-alone therapy compared to insulin injection therapy in diabetic cats - Research Communications of the 32nd ECVIM-CA Online Congress. Journal of Veterinary Internal Medicine. 2022;36(6):2455–551. [CrossRef] [Google Scholar]
  • Hadd MJ, Bienhoff SE, Little SE, Geller S, Ogne-Stevenson J, Dupree TJ, et al. Safety and effectiveness of the sodium-glucose cotransporter inhibitor bexagliflozin in cats newly diagnosed with diabetes mellitus. J Vet Intern Med. 2023;37(3):915–24. [CrossRef] [Google Scholar]
  • Nelson R, Spann D, Elliott D, Brondos A, Vulliet R. Evaluation of the oral antihyperglycemic drug metformin in normal and diabetic cats. J Vet Intern Med. 2004;18(1):18–24. [CrossRef] [PubMed] [Google Scholar]
  • Mazzaferro EM, Greco DS, Turner AS, Fettman MJ. Treatment of feline diabetes mellitus using an alpha-glucosidase inhibitor and a low-carbohydrate diet. J Feline Med Surg. 2003;5(3):183–9. [CrossRef] [PubMed] [Google Scholar]
  • Feldman EC, Nelson RW, Feldman MS. Intensive 50-week evaluation of glipizide administration in 50 cats with previously untreated diabetes mellitus. J Am Vet Med Assoc. 1997;210(6):772–7. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.